Hemcheck's Newsletter - April 2021

Welcome to the April Newsletter from Hemcheck

We are continuing our journey with several interesting events and news this month. We have signed new distributor agreements in the Middle East, we have had positive results from clinical studies in Barcelona, Spain, and there are also more tests and studies planned or ongoing with other centers and potential customers. The collaborations with Medicine, France, and Medscaler, Netherlands, are also continuing where they are helping us setting up local customer meetings.

We are at the same time focusing hard on building the team. The new CTO, David Melin, has during April started the work to lead our product development efforts. We have also hired a new Production & Logistics Manager, Sara Köhl. Sara is starting her position in August. There are other planned recruitments such as a Quality Assurance Manager and a Clinical Specialist. These processes are running as of now and hopefully we will be able to announce some more news on this shortly. In addition we made a strong contribution to the overall Hemcheck team by establishing a clinical advisory board, consisting of four distinguished professors from relevant medical fields and different parts of Europe.

Other than this, we have also filed a new patent application regarding a product system for the blood gas market, which is in line with our strategy to have strong IP-protection.

You can read about this, and more, in this April Newsletter.

Enjoy the reading!
Joen Averstad, CEO
noun_thumbs up_538609

New Production & Logistics Manager in Hemcheck

Hemcheck has hired Sara Köhl as the new Production & Logistics Manager. Sara will start in August and comes from the position as Production Engineer and Team Leader at Corline Biomedical, where she has been for over 5 years.

We are very happy that Sara will be joining the team. We think that Sara will fit in very well in the team that we want to build for the future and we are convinced that she will contribute a lot in our continuing journey.

Read more

Distribution agreement signed regarding distribution in Saudi Arabia

Hemcheck has signed an exclusive distribution agreement with Abdulla Fouad for Medical Supplies and Services Company (“AFMS”), a leading distributor of laboratory and medical equipment in Saudi Arabia. The agreement will be in force from April and valid until the end of September 2023, concerning the Saudi Arabian market. AFMS has committed to an initial purchase order of readers and one-time tests for a value of 8,000 EUR.

- We are very happy to start this collaboration with Hemcheck. They have a very interesting and unique solution. We look forward to initiating the local registration process and start the efforts to approach customers, says Faisal Abdulla Fouad, Chairman of Abdulla Fouad Group.

Read more
Abdulla Fouad for Medical Supplies and Services Company (“AFMS”)

Distribution agreement signed regarding distribution in Bahrain

Hemcheck has signed an exclusive distribution agreement with General Medical W.L.L (“General Medical”), a leading distributor of medical equipment in Bahrain. The agreement is valid until the end of April 2023, concerning the Bahraini market.

– We are very pleased to have signed this distributor agreement with Hemcheck. They have an innovative solution, and we believe there is good potential for the products in our market. We look forward to the collaboration, says Mohammed Merajuddin, Deputy General Manager, of General Medical.

Read more

Hemcheck establishes an international clinical advisory board

Hemcheck Sweden AB has established an international clinical advisory board. The board will act as advisors to the company with regards to the continued work of building clinical evidence, evaluation of products and future product development. The board will consist of four experts active in the fields of acute medicine, internal medicine, and laboratory medicine. The four experts are Professor Salvatore Di Somma from Rome, Professor Olle Melander from Lund, Professor Jorge Ordonez-Llanos from Barcelona, and Professor Michael Christ from Luzern.

Read more

Hemcheck applies for a new patent

regarding a product system for the blood gas market

Hemcheck Sweden AB has filed a new patent application regarding a product system for the blood gas market. This is according to the current strategy to protect the company’s intellectual property. This application is partly based on the development work that has been done since last year regarding a new product for the blood gas market.

Hemcheck cannot release more information about the patent application today. The application will be handled according to current patent application processes. Hemcheck will, as soon as it is possible, release more information to the market.

Read more
Hemcheck_logo_line_preview 2

Upcoming events 2021

May 17th
SFAT Emergency & Traumasurgery days

May 24th
ISBER 2021 Annual Meeting & Exhibits

May 25th
28th Congress of Biomedical Analytics Austria
Contact Us
Hemcheck Sweden AB
Karlstads universitet
Universitetsgatan 2
651 88 Karlstad